Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab. [electronic resource]
Producer: 20121126Description: 178-83 p. digitalISSN:- 1521-0103
- Animals
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Drug Therapy, Combination
- Female
- Humans
- Imidazoles -- administration & dosage
- Lymphoma, B-Cell -- diagnostic imaging
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mice, SCID
- Naphthoquinones -- administration & dosage
- Radionuclide Imaging
- Rituximab
- Treatment Outcome
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.